Published in Vopr Pitan on June 14, 1989
Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc Natl Acad Sci U S A (1988) 1.38
[The tactics of management of patients with mycobacteriosis of the lungs]. Probl Tuberk (1991) 1.38
Continuous subendothelial network formed by pericyte-like cells in human vascular bed. Tissue Cell (1998) 1.05
Subendothelial smooth muscle cells of human aorta express macrophage antigen in situ and in vitro. Atherosclerosis (1997) 1.04
Cell proliferation in normal and atherosclerotic human aorta. I. Flow cytofluorometric determination of cellular deoxyribonucleic acid content. Lab Invest (1983) 1.00
Vascular smooth muscle cell in atherosclerosis. Acta Physiol (Oxf) (2015) 0.97
Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima. Light-microscopic study of dissociated aortic cells. Am J Pathol (1984) 0.94
Desialylated low density lipoprotein--naturally occurring modified lipoprotein with atherogenic potency. Atherosclerosis (1991) 0.93
Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability. Acta Physiol (Oxf) (2015) 0.93
Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. Biochem Biophys Res Commun (1989) 0.92
Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins. Biochem Biophys Res Commun (1989) 0.92
Local prevention of thrombosis in animal arteries by means of magnetic targeting of aspirin-loaded red cells. Thromb Res (1990) 0.92
Evidence of antiatherosclerotic action of verapamil from direct effects on arterial cells. Am J Cardiol (1987) 0.92
[Variability of intima-media thickness of the common carotid arteries in Moscow city population without clinical symptoms of atherosclerosis]. Ter Arkh (2011) 0.91
[Molecular genetic characterization of the HIV-1 variants abundant in Kirgiziia]. Vopr Virusol (2012) 0.91
Collagen-synthesizing cells in initial and advanced atherosclerotic lesions of human aorta. Atherosclerosis (1997) 0.90
Cell proliferation in normal and atherosclerotic human aorta. II. Autoradiographic observation on deoxyribonucleic acid synthesis in primary cell culture. Lab Invest (1983) 0.90
The atherogenic effect of lupus sera: systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta. Clin Immunol Immunopathol (1992) 0.89
Dissociated cells from different layers of adult human aortic wall. Acta Anat (Basel) (1984) 0.89
Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo. Biochem Biophys Res Commun (1995) 0.89
Hydrolysis of cholesteryl ester in low density lipoprotein converts this lipoprotein to a liposome. J Biol Chem (1992) 0.88
Direct anti-atherosclerosis-related effects of garlic. Ann Med (1995) 0.88
[Alpha-fetoprotein suppresses keratinocyte proliferation in vitro]. Izv Akad Nauk Ser Biol (1996) 0.86
Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents. Atherosclerosis (1986) 0.86
Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease. J Lipid Res (1993) 0.86
Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation. Circ Res (1992) 0.86
Trapidil derivatives as potential antiatherosclerotic drugs. Arzneimittelforschung (1987) 0.86
Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation. Arterioscler Thromb (1991) 0.85
Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease. Coron Artery Dis (1993) 0.85
Stellate cells in the intima of human aorta. Application of alkaline dissociation method in the analysis of the vessel wall cellular content. Acta Anat (Basel) (1983) 0.85
Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima. Exp Mol Pathol (1997) 0.85
Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification. Atherosclerosis (1998) 0.85
Dibutyryl cyclic AMP decreases proliferative activity and the cholesteryl ester content in cultured cells of atherosclerotic human aorta. Biochem Biophys Res Commun (1982) 0.85
[Circulation of West Nile virus (Flaviviridae, Flavivirus) and some other arboviruses in the ecosystems of Volga delta, Volga-Akhtuba flood-lands and adjoining arid regions (2000-2002)]. Vopr Virusol (2004) 0.84
Intimal cells and atherosclerosis. Relationship between the number of intimal cells and major manifestations of atherosclerosis in the human aorta. Am J Pathol (1986) 0.84
[Direct antiatherosclerotic therapy: possible approaches, results of clinical trials]. Patol Fiziol Eksp Ter (2014) 0.84
Stable analogues of prostacyclin and thromboxane A2 display contradictory influences on atherosclerotic properties of cells cultured from human aorta. The effect of calcium antagonists. Atherosclerosis (1988) 0.84
Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein. Atherosclerosis (2001) 0.83
Autoantibodies against low-density lipoprotein and atherogenic potential of blood. Ann Med (1993) 0.83
Atherogenicity of blood serum from patients with coronary heart disease. Lancet (1986) 0.83
Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its elimination. Circ Res (1988) 0.83
[Study of intima-medial thickness (IMT) of the carotid arteries as an indicator of natural atherosclerosis progress in Moscow population]. Patol Fiziol Eksp Ter (2012) 0.83
Lipoprotein immune complexes as markers of atherosclerosis. Int J Tissue React (1991) 0.83
Cardiovascular drugs and atherosclerosis: effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells. J Cardiovasc Pharmacol (1988) 0.83
[Study of cell culture of mouse submandibular salivary gland in vitro]. Tsitologiia (2011) 0.82
Expression of keratin 19 in a culture of human epidermal keratinocytes. Dokl Biol Sci (2006) 0.82
Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography. Biochem Biophys Res Commun (1990) 0.82
Lack of correlation between degree of human plasma low density lipoprotein oxidation and its atherogenic potential. Biofactors (1997) 0.82
Correlation between cholesterol content in circulating immune complexes and atherogenic properties of CHD patients' serum manifested in cell culture. Atherosclerosis (1990) 0.81
Low-density lipoproteins isolated from the blood of patients with coronary heart disease induce the accumulation of lipids in human aortic cells. Exp Mol Pathol (1989) 0.81
Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. J Lipid Res (1992) 0.81
[The Trp64Arg polymorphism of beta3-adrenoreceptor gene study in persons with overweight and obesity]. Vopr Pitan (2012) 0.81
Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells. Atherosclerosis (1993) 0.81
[Effect of dietary selenium on the activity of UDP-glucuronosyltransferases and metabolism of mycotoxin deoxynivalenol in rats]. Vopr Pitan (1998) 0.81
[Hypotensive effect of long-acting garlic tablets allicor (a double-blind placebo-controlled trial)]. Ter Arkh (2002) 0.80
[Cholesterol of circulating immune complexes as biomarker of atherosclerosis]. Patol Fiziol Eksp Ter (2012) 0.80
Stellate cells of aortic intima: I. Human and rabbit. Tissue Cell (1992) 0.80
Contents of mRNAs encoding endosome/lysosome components in normal human aorta and in stage II of atherogenesis: a hidden regulation. Biochemistry (Mosc) (2011) 0.80
Antiatherogenic effect of grape flavonoids in an ex vivo model. Bull Exp Biol Med (2006) 0.80
Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization. Lab Invest (1992) 0.80
Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions. Exp Mol Pathol (1995) 0.80
[A new method of quantitative estimation of mutant allele in mitochondrial genome]. Patol Fiziol Eksp Ter (2012) 0.80
[Epidermal stem cells]. Izv Akad Nauk Ser Biol (2005) 0.79
Primary cultures of enzyme-isolated cells from normal and atherosclerotic human aorta. Med Biol (1984) 0.79
Triggerlike stimulation of cholesterol accumulation and DNA and extracellular matrix synthesis induced by atherogenic serum or low density lipoprotein in cultured cells. Circ Res (1990) 0.79
[Nutrition and health of population in the North: priority guidelines]. Med Tr Prom Ekol (1996) 0.79
Use of cell culture for optimisation of direct antiatherogenic therapy with verapamil. Drugs (1992) 0.79
Characteristics of low density lipoprotein isolated from circulating immune complexes. Atherosclerosis (1996) 0.79
In vitro effect of garlic powder extract on lipid content in normal and atherosclerotic human aortic cells. Lipids (1997) 0.79
Adult human aortic cells in primary culture: heterogeneity in shape. Heart Vessels (1986) 0.79
Optimization of the assay for sialic acid determination in low density lipoprotein. J Lipid Res (1998) 0.79
Vascular signal transduction and atherosclerosis. Ann N Y Acad Sci (1990) 0.79
[Tuberculosis of the lungs complicated by opisthorchiasis under conditions of the extreme north]. Probl Tuberk (1989) 0.79
[Culture of human amniotic fluid stem cells in 3D collagen matrix]. Tsitologiia (2011) 0.79
Diagnostic value of immune cholesterol as a marker for atherosclerosis. J Cardiovasc Risk (1995) 0.79
Lipids in cells of atherosclerotic and uninvolved human aorta. III. Lipid distribution in intimal sublayers. Exp Mol Pathol (1991) 0.79
Characterization of desialylated low-density lipoproteins which cause intracellular lipid accumulation. Int J Tissue React (1992) 0.78
Low density lipoprotein-containing circulating immune complexes and coronary atherosclerosis. Exp Mol Pathol (1990) 0.78
Comparative contents of mRNAs of sex steroid receptors and enzymes of their metabolism in arterial walls of men. Biochemistry (Mosc) (2008) 0.78
Artificial HDL as an anti-atherosclerotic drug. Lancet (1984) 0.78
Primary RIA screening of hybridoma supernatants without use of a negative control. J Immunol Methods (1985) 0.78
Content and localization of fibronectin in normal intima, atherosclerotic plaque, and underlying media of human aorta. Atherosclerosis (1984) 0.78
[Circulating immune complex cholesterol as a biochemical marker of coronary atherosclerosis]. Kardiologiia (1991) 0.78
Beta-blockers: propranolol, metoprolol, atenolol, pindolol, alprenolol and timolol, manifest atherogenicity on in vitro, ex vivo and in vivo models. Elimination of propranolol atherogenic effects by papaverine. Atherosclerosis (1992) 0.78
Intracellular cholesterol accumulation is accompanied by enhanced proliferative activity of human aortic intimal cells. Tissue Cell (1988) 0.78